Kanwar, Manreet K.
Allegheny Health Network
2 papers on CoChatORCID 0000-0002-7280-5268
Most cited papers
- Verified
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: A multicenter randomized trial
Nassif, M. E., Windsor, S. L., Borlaug, B. A., Kitzman, D. W., Shah, S. J., Tang, F., Khariton, Y., Malik, A. O., Khumri, T., Umpierrez, G., et al. (2021) · Nature Medicine
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 618
- Verified
Effect of dapagliflozin in DAPA-HF according to background glucose-lowering therapy
Docherty, K. F., Jhund, P. S., Bengtsson, O., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., Martinez, F. A., Sabatine, M. S., et al. (2020) · Diabetes Care
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free